首页 | 本学科首页   官方微博 | 高级检索  
     

曲美他嗪联合培哚普利治疗慢性充血性心力衰竭疗效观察
引用本文:肖兰平. 曲美他嗪联合培哚普利治疗慢性充血性心力衰竭疗效观察[J]. 中国现代医药杂志, 2008, 10(10)
作者姓名:肖兰平
作者单位:湖南省冷水江市人民医院,417500
摘    要:目的观察曲美他嗪(TMZ)联合培哚普利治疗慢性充血性心力衰竭(CHF)患者的临床疗效。方法72例CHF患者随机分为研究组和对照组,均给予内科常规抗心衰治疗。对照组加服培哚普利,初始剂量2mg,每日1次,逐渐加至靶剂量4mg,每日1次;研究组在对照组的基础上接受曲美他嗪20mg/次,3次/d。治疗12周。结果治疗12周,两组心功能较治疗前有明显改善,治疗组临床总有效率为93.4%,较对照组(80.6%)显著提高(P〈0.05);超声心动图LVEF均较治疗前有明显改善(P〈0.01或P〈0.051.但治疗组较对照组改善更为显著(P〈0.05)。治疗组LVEDD、LVESD、LADD均较治疗前改善,差异有显著性(P〈0.01或P〈0.05),而对照组无改善;两组均未发现有明显的不良反应。结论TMZ联合培哚普利治疗CHF是一种安全有效的方法。

关 键 词:充血性心力衰竭  曲美他嗪  培哚普利

Observation of the curative effect of trimetazidine combined perindopril treatment for chronic congestive heart failure
Xiao Lanping. Observation of the curative effect of trimetazidine combined perindopril treatment for chronic congestive heart failure[J]. Modern Medicine Journal of China, 2008, 10(10)
Authors:Xiao Lanping
Affiliation:Xiao Lanping.The people's hospital of Lengshuijiang,Hunan 417500
Abstract:Objective To observe the curative effect of trimetazidine (TMZ) combined perindopril treatment of chronic congestive heart failure (CHF). Methods 72 patients with CHF were randomly divided into experimental group and control group, all patients were given conventional medical treatment. The control group plus service culture Perindopril, the initial dose of 2mg/d, gradually increased to target dose of 4mg /d;Experimental group acceptance of trimetazidine 20mg, tid, additionally. 12 weeks later, the curative...
Keywords:Congestive heart failure Trimetazidine Perindopril  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号